Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/14/13 → 09/7/17 |
Funding
- Amgen Incorporated: $17,181.53
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy In Patients with....
- Lawson, William (CoPI)
- Gruberg, Luis (PI)
- Jeremias, Allen (CoPI)
Project: Research